Pages Tagged with "Press Release"
Music industry icons Lyor Cohen, 2023 City of Hope Spirit of Life® honoree, and Sylvia Rhone, 2019 Spirit of Life honoree, host leaders from across the music, film and entertainment...
The precision medicine technology is being used for patients with metastatic lung and bone tumors at City of Hope’s Los Angeles location and could treat more cancers in the future ...
Discovery could lead to targeted new treatments for aggressive cancer of the bone marrow
CONTACT
Zen Logsdon
626-409-9367
zlogsdon@coh.org
The return (i.e., homing) of leukemia stem cells (green) to the bone marrow microenvironment/niche (red) is substantially enhanced by low levels of TET2, at right, compared to the wild-type version of the gene. (Jianjun Chen Laboratory / City of Hope)
FINDINGS
Scientists at City of Hope, one of the largest...
The identification of a cell metabolism process found in Black men with diabetes and prostate cancer could one day lead to the development of a disease prediction tool for this...
Finding could lead to a new class of drugs to address cardiovascular side effects of some cancer therapies.
CONTACT
Zen Logsdon
626-409-9367
zlogsdon@coh.org
Allosteric communication (shown as pipelines) spreads all around the protein structure, revealing multiple binding sites that can be harnessed for drug design. (Image credit: Wijnand J.C. van der Velden, Ph.D., co-first author of the study and a postdoctoral fellow in computational and quantitative medicine at Beckman Research Institute of City of Hope.)
FINDINGS
Scientists at City of Hope, one...
LOS ANGELES — There are currently few effective treatment options for patients with recurrent ovarian cancer and other solid tumors, but City of Hope researchers are trying to change that. ...
The CIRM funds will support cell and gene therapy clinical trials for HIV, leukemia and a bone marrow disease
CONTACT
Zen Logsdon
626-409-9367
zlogsdon@coh.org
LOS ANGELES — Researchers at...
LOS ANGELES — City of Hope, one of the largest cancer research and treatment organizations in the United States, was recognized as the eighth “Best Hospital” for cancer in the...
The City of Hope-developed investigational small molecule selectively disrupts DNA replication and repair in cancer cells, leaving healthy cells unaffected, a new study reports.
The City of Hope-developed small molecule AOH1996 targets a cancerous variant of the protein PCNA. In its mutated form, PCNA is critical in DNA replication and repair of all expanding tumors. Here we see untreated cancer cells (left) and cancer cells treated with AOH1996 (right) undergoing programmed cell death (violet). (Photo credit: City of Hope)
LOS ANGELES — Researchers at...
For Media:City of HopeLetisia Marquezlemarquez@coh.org(626) 476-7593Calidi BiotherapeuticsStephen ThesingSthesing@calidibio.com (858) 794-9600For Investors:Gilmartin GroupStephen Jasperstephen@gilmartinir.com LOS ANGELES and SAN DIEGO, Calif. ...